Verici Dx plc (VRCI.L)

LSE • Market Data in GBP, Fundamentals in USD Market GBP / Fundamentals USD

£1.00

-£0.13

-11.11%

Last Update: 17 Jul 2025, 13:00

£2.43M

Market Cap

0.00

P/E Ratio (TTM)

P/E Ratio

—

Forward Dividend Yield

Forward Yield

£0.90 - £8.50

52 Week Range

VRCI.L Stock Price Chart

Explore Verici Dx plc interactive price chart. Choose custom timeframes to analyze VRCI.L price movements and trends.

There is nothing to show.

VRCI.L Company Profile

Discover essential business fundamentals and corporate details for Verici Dx plc (VRCI.L) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

IPO Date

3 Nov 2020

Employees

19.00

Website

https://www.vericidx.com

CEO

Sara jane Barrington A.C.I.M.

Description

Verici Dx plc, an immuno-diagnostics development company, focuses on the kidney transplantation market. The company develops prognostic and diagnostic tests for kidney transplant patients. Its in-development tests include Clarava, a pre-transplant prognosis test for the risk of early acute rejection; Tuteva, a post-transplant test that focuses on acute cellular rejection; and Protega, a liquid biopsy that aims to predict the risk of fibrosis and long-term graft failure. The company was incorporated in 2020 and is based in Penarth, the United Kingdom.

VRCI.L Financial Timeline

Browse a chronological timeline of Verici Dx plc corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 1 Jun 2026

Earnings released on 30 Jun 2025

Earnings released on 2 Jun 2025

Earnings released on 15 Jul 2024

EPS came in at -£0.00, while revenue for the quarter reached £2.64M.

Earnings released on 30 May 2024

EPS came in at -£0.02, while revenue for the quarter reached £786.61K, missing expectations by -86.74%.

Earnings released on 5 Oct 2023

EPS came in at -£0.02, while revenue for the quarter reached £15.00K.

Earnings released on 5 Jun 2023

EPS came in at -£0.03.

Earnings released on 7 Sept 2022

EPS came in at -£0.03.

Earnings released on 31 Dec 2021

EPS came in at -£0.03.

Earnings released on 30 Jun 2021

EPS came in at -£0.01.

Earnings released on 31 Dec 2020

EPS came in at -£0.06.

VRCI.L Stock Performance

Access detailed VRCI.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.